WILLIAM PEACOCK to Hyperkalemia
This is a "connection" page, showing publications WILLIAM PEACOCK has written about Hyperkalemia.
Connection Strength
5.181
-
Patiromer utility as an adjunct treatment in patients needing urgent hyperkalaemia management (PLATINUM): design of a multicentre, randomised, double-blind, placebo-controlled, parallel-group study. BMJ Open. 2023 06 12; 13(6):e071311.
Score: 0.748
-
The Increased Clinical and Economic Burden of Hyperkalemia in Medicare Patients Admitted to Long-Term Care Settings. Adv Ther. 2023 03; 40(3):1204-1223.
Score: 0.727
-
Emergency Potassium Normalization Treatment Including Sodium Zirconium Cyclosilicate: A Phase II, Randomized, Double-blind, Placebo-controlled Study (ENERGIZE). Acad Emerg Med. 2020 06; 27(6):475-486.
Score: 0.599
-
Rapid correction of hyperkalemia is associated with reduced mortality in ED patients. Am J Emerg Med. 2020 11; 38(11):2361-2364.
Score: 0.586
-
Patiromer for Treatment of Hyperkalemia in the Emergency Department: A Pilot Study. Acad Emerg Med. 2020 01; 27(1):54-60.
Score: 0.585
-
Response to Letter to the Editor. J Emerg Med. 2019 10; 57(4):575.
Score: 0.579
-
Real World Evidence for Treatment of Hyperkalemia in the Emergency Department (REVEAL-ED): A Multicenter, Prospective, Observational Study. J Emerg Med. 2018 Dec; 55(6):741-750.
Score: 0.543
-
Expert Panel Recommendations for the Identification and Management of Hyperkalemia and Role of Patiromer in Patients with Chronic Kidney Disease and Heart Failure. J Manag Care Spec Pharm. 2017 Apr; 23(4-a Suppl):S10-S19.
Score: 0.487
-
Emergency management of severe hyperkalemia: Guideline for best practice and opportunities for the future. Pharmacol Res. 2016 11; 113(Pt A):585-591.
Score: 0.117
-
Sodium zirconium cyclosilicate for urgent therapy of severe hyperkalemia. N Engl J Med. 2015 Apr 16; 372(16):1577-8.
Score: 0.106
-
Sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalemia. Expert Opin Pharmacother. 2015; 16(11):1727-34.
Score: 0.104